Following that, we explored the relationship between TFAP2A expression with Immune checkpoint (ICP) genes, immune subtypes, immune cell infiltrations, immunotherapy efficacy, and PD-L1 expression in cancer cell lines to unravel the role of TFAP2A from the perspective of tumor immunity. This evidence concerns the gene CD274 and neoplasm.